<prompt> Answer this question truthfullyWhat is the potential risk of passive immunotherapy, particularly in patients with selective deficiency of a specific immunoglobulin?  <response>: <reason> One risk of passive immunotherapy is IgE production and anaphylaxis, especially in patients with selective IgA deficiency. 